Maria Betty Grace Bontigao-Emocling: 7 Years of Purpose-Driven Leadership at Boehringer Ingelheim
Maria Betty Grace Bontigao-Emocling, Therapeutic Area Lead – Cardiovascular and Lytics Business at Boehringer Ingelheim, shared a post on LinkedIn:
”Celebrating 7 years at Boehringer Ingelheim today-and feeling incredibly proud of the journey.
Over the years, I’ve been entrusted to lead and contribute across cardiovascular, respiratory, specialty care, rare disease, and now thrombosis care.
Each therapeutic area brought new challenges, deeper responsibility, and the opportunity to grow as a leader.
I’m grateful for leaders who believed in me, mentors who challenged me, and teammates who consistently show what excellence and collaboration look like. It’s an honor to help shape patient journeys and work alongside passionate key opinion leaders who share the same purpose.
Most proud to be leading a dynamic, resilient, and high‑performing One Stroke Care Team-a group driven by impact, teamwork, and commitment to patients.
Looking forward to more milestones, growth, and meaningful impact in the years ahead.”
Stay updated with Hemostasis Today.
-
Jun 26, 2026, 05:50Andrew Emad: Five Years of Partnership, Innovation, and Impact at Africa Health ExCon 2026
-
Jun 26, 2026, 05:48Regan Bucciol: The Emerging Role of Erythrocytes in Thrombosis
-
Jun 26, 2026, 05:26Maxime Dely: Strengthening Skills in Plasma and Red Cell Exchange
-
Jun 26, 2026, 05:26Andreas Calatzis: Hidden Differences in Anti-Xa Testing
-
Jun 26, 2026, 04:56Recognizing the 2026 ISTH Fundamental Research Career Development Award Recipients
-
Jun 26, 2026, 04:42Jonathan James: Amplifying Voices Across the Bleeding Disorders Community
-
Jun 26, 2026, 04:02Rick Kapur: Advancing Hematology Through Global Collaboration at EHA 2026 and ISBT
-
Jun 26, 2026, 02:06Giovanni Merlino: Scientific Progress in Secondary Stroke Prevention at Udine Stroke Congress 2026
-
Jun 26, 2026, 01:48Michael Stark: Highlights from ISBT 2026 on RBC Transfusion and NEC in Neonates